Small molecule program (Atengen)
N/A
Report date: 2022/07/26 10:28:56
NME
Base Information
Drug NameSmall molecule program (Atengen)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtengen Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A